Status:
RECRUITING
HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain
Lead Sponsor:
Rhode Island Hospital
Conditions:
Chronic Low-back Pain
Chronic Pain
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to examine the effect of rationale condition when taking open-label placebos on pain by 1) comparing each rationale to the no rationale control condition and the no ...
Eligibility Criteria
Inclusion
- Inclusion criteria are:
- chronic pain (pain lasting at least 3 months, pain intensity 4/10 or over and interference 3/10 or over)
- at least 18 years old
- English speaking
- have a smartphone or computer with video access
- the chronic pain is concentrated into the patient's lower back (tentative criteria based on recruitment rate)
- Exclusion Criteria
- Have chronic pain because of a cancer diagnosis
- Over 89 years of age
- Suspect an allergy to any placebo ingredient
- Currently receiving worker's compensation.
Exclusion
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT06931158
Start Date
March 1 2025
End Date
March 1 2027
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02906